Raymond James & Associates Pfizer Inc Call Options Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

Call Options

24 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 Apr 14, 2023	SELL	$39.39 - $51.28 $1.16 Million - $1.51 Million	-29,400 Reduced 98.66%	400 $16,000
Q4 2022 Feb 08, 2023	SELL	$41.75 - $54.5 $50,100 - $65,400	-1,200 Reduced 3.87%	29,800 $1.53 Million
Q3 2022 Oct 25, 2022	BUY	$43.76 - $53.42 $201,296 - $245,732	4,600 Added 17.42%	31,000 $61,000
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $2.11 Million - $2.5 Million	-45,400 Reduced 63.23%	26,400 $239,000
Q1 2022 May 11, 2022	SELL	$45.75 - $56.69 $695,400 - $861,688	-15,200 Reduced 17.47%	71,800 $678,000
Q4 2021 Feb 08, 2022	SELL	$41.32 - $61.25 $818,136 - $1.21 Million	-19,800 Reduced 18.54%	87,000 $1.24 Million
Q3 2021 Nov 02, 2021	SELL	$39.25 - $50.42 $1.55 Million - $1.99 Million	-39,400 Reduced 26.95%	106,800 $266,000
Q2 2021 Aug 11, 2021	BUY	$35.91 - $40.68 $1.24 Million - $1.4 Million	34,500 Added 30.89%	146,200 $89,000
Q1 2021 May 14, 2021	BUY	$33.49 - $37.77 $991,304 - $1.12 Million	29,600 Added 36.05%	111,700 $54,000
Q4 2020 Feb 12, 2021	BUY	$33.47 - $42.56 $1.02 Million - $1.29 Million	30,400 Added 58.8%	82,100 $17,000
Q3 2020 Nov 04, 2020	BUY	$31.75 - $37.25 $479,425 - $562,475	15,100 Added 41.26%	51,700 $28,000
Q2 2020 Jul 28, 2020	SELL	$30.12 - $36.54 $5.42 Million - $6.57 Million	-179,900 Reduced 83.09%	36,600 $9,000
Q1 2020 Apr 21, 2020	BUY	$27.03 - $38.62 $383,826 - $548,404	14,200 Added 7.02%	216,500 $56,000
Q4 2019 Feb 12, 2020	BUY	$32.92 - $37.36 $164,600 - $186,800	5,000 Added 2.53%	202,300 $40,000
Q3 2019 Nov 07, 2019	SELL	$32.49 - $42.13 $4.31 Million - $5.59 Million	-132,600 Reduced 40.19%	197,300 $18,000
Q2 2019 Aug 06, 2019	BUY	$36.98 - $41.52 $3.98 Million - $4.46 Million	107,500 Added 48.34%	329,900 $204,000
Q1 2019 May 06, 2019	BUY	$37.5 - $41.2 $3.05 Million - $3.35 Million	81,400 Added 57.73%	222,400 $38,000
Q4 2018 Feb 11, 2019	SELL	$38.47 - $43.86 $6.78 Million - $7.73 Million	-176,200 Reduced 55.55%	141,000 $183,000
Q3 2018 Nov 14, 2018	BUY	$34.47 - $41.81 $3.14 Million - $3.81 Million	91,200 Added 40.35%	317,200 $878,000
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $916,843 - $977,447	-27,800 Reduced 10.95%	226,000 $126,000
Q1 2018 May 14, 2018	SELL	$31.91 - $37.02 $3.05 Million - $3.54 Million	-95,600 Reduced 27.36%	253,800 $164,000
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $1.35 Million - $1.43 Million	-40,600 Reduced 10.41%	349,400 $209,000
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $2.32 Million - $2.55 Million	74,700 Added 23.69%	390,000 $310,000
Q2 2017 Aug 14, 2017	BUY	N/A	315,300	315,300 $63,000

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

Vanguard Group Inc Valley Forge, PA

511M
Shares

$14 Billion
0.28% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.7 Billion
0.27% of portfolio
State Street Corp Boston, MA

287M
Shares

$7.88 Billion
0.36% of portfolio
Wellington Management Group LLP Boston, MA

166M
Shares

$4.57 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

117M
Shares

$3.22 Billion
0.63% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account